Pharvaris publishes AAE-C1INH disease burden study in Frontiers in Immunology

Go back to Pharvaris publishes AAE-C1INH disease burden study in Frontiers in Immunology
(NASDAQ: PHVS) Delayed: 32.19 -0.8 (2.42%)
Previous Close $32.99    52 Week High $ 
Open $33.08    52 Week Low $ 
Day High $33.62    P/E N/A 
Day Low $32.04    EPS $ 
Volume 283,890